Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?

@article{Baldin1997AlternativeSO,
  title={Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?},
  author={V{\'e}ronique Baldin and Christophe Cans and Giulio Superti-Furga and Bernard Ducommun},
  journal={Oncogene},
  year={1997},
  volume={14},
  pages={2485-2495}
}
CDC25B2, a protein tyrosine phosphatase closely related to the putative CDC25B oncogene, was identified in a Burkitt lymphoma cDNA library. CDC25B2 differs from CDC25B by a 14 residue insertion and a 41 residue deletion, which are both located in the amino-terminal region of the protein, upstream of the catalytic domain. Examination of the genomic sequence revealed that CDC25B1 (formerly B) and CDC25B2 are splice variants of the same gene. A third variant, CDC25B3, that carries both the 14 and… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

Differential Expression of cdc25 Cell-Cycle–Activating Phosphatases in Human Colorectal Carcinoma

Silvia Hernández, Xavier Bessa, +8 authors Elías Campo
  • Laboratory Investigation
  • 2001
VIEW 7 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Differential expression of CDC25 phosphatases splice variants in human breast cancer cells.

  • Clinical chemistry and laboratory medicine
  • 2011
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-3 OF 3 REFERENCES

J

NK Hatward, Ellem KAO.
  • Cell. Science,
  • 1996

Oncogene, 11, 1005 ± 1011

WD, J. Heighway
  • Booher RN, Deshaies RJ and Kirschner MW. (1993). EMBO
  • 1995

Genomics, 15, 693 ± 694

K. Ellem
  • Mazars P, Barboule N, Baldin V, Vidal S, Ducommun B and
  • 1993